Filing Details

Accession Number:
0001225208-18-005645
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-07 16:09:40
Reporting Period:
2018-03-06
Accepted Time:
2018-03-07 16:09:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
78003 Pfizer Inc PFE Pharmaceutical Preparations (2834) 135315170
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1508517 H Charles Hill Pfizer Inc.-Corp. Secretary
235 East 42Nd St.
New York NY 10017
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-03-06 316 $35.81 99,405 No 4 S Direct
Common Stock Disposition 2018-03-06 330 $35.80 99,075 No 4 S Direct
Common Stock Disposition 2018-03-06 493 $35.79 98,582 No 4 S Direct
Common Stock Disposition 2018-03-06 10,715 $35.70 87,867 No 4 S Direct
Common Stock Disposition 2018-03-06 30,539 $35.78 57,328 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 11,414 Indirect By Rule 16b-3 Plan